Find A Presenter:
Born and raised in inner city Chicago, Irene Aguilar was the first in her family to receive a bachelor’s degree. She attended Washington University in St. Louis on a scholarship and received her medical degree from the University of Chicago-Pritzker School of Medicine.Amendment 69: ColoradoCare? Yes!
Jandel Allen-Davis, MD, is vice president of Government, External Relations and Research for Kaiser Permanente Colorado. She leads the organization’s community relations, communications, advertising and marketing functions, stakeholder engagement, government relations, clinical research activities and community benefit investment.Health: The Heart of Health Care Reform
Stephen Ansolabehere is Professor of Government at Harvard University. He is an expert in public opinion and elections, and has published extensively on elections, mass media, and representation, political economy, and public opinion, especially concerning energy and the environment.Energy and Climate Policy and the Lessons for Healthcare
I began my research career by studying lipid and lipoprotein metabolism. In mid-career, I switched to work on genetics of obesity and diabetes.Bottlenecks in Evolution, Bottlenecks in Type 2 Diabetes
Emmanuel E. Baetge is the director of the new Nestlé Institute of Health Sciences, located at the Swiss Federal Institute of Technology in Lausanne (EPFL).The Scientific Challenge of expanding the Frontiers of Nutrition
Richard is an internationally respected leader in healthcare and life sciences. He is Founding Director of the Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), a major UK initiative aimed at transforming the R&D and regulatory processes in life sciences to bring advances more rapidly and affordably to patients.Bioscience – Lost in Translation?
Michael F. Bennet was elected United States Senator for Colorado in November 2010.
Ian Billick is a field biologist who is interested in the ecology and evolution of complex systems. He earned a BA in Math and Physics at Trinity University (Texas) in 1988 and a PhD in Biology at the University of California San Diego in 1997.Complex Systems, Idiosyncracy, and Scarce Data: Observations from the Field
Tom Blumenthal is the Anna and John J. Sie Professor in Genomics at the University of Colorado School of Medicine, where he is executive director of the Linda Crnic Institute for Down Syndrome.The Unrealized Value to Society of Understanding Down Syndrome
Patricia Flatley Brennan is the Director of the NLM, a component of the NIH. The NLM is the world’s largest biomedical library and the producer of digital information services used by scientists, health professionals, and members of the public worldwide.
Sarah Burgamy, Psy.D. is the founder of a private practice in Denver, Colorado, PhoenixRISE, with specialty offerings in identity development (considering intersections of target and non-target status identities), sexual minority competency as well as transgender and gender variant issues with children, adolescents, and adults.Gender Re/Evolution: Navigating Developmental, Psychological and Social Facets of Pink and Blue in a Purple World
Paula Cannon, Ph.D. is a professor of molecular microbiology and immunology at the Keck School of Medicine of the University of Southern California. She leads a research team that studies viruses, stem cells, and gene therapy, with an emphasis on HIV/AIDS.Targeted Nucleases—Human Gene Therapy 2.0?
Dr. Elvir Causevic leads Ocean Tomo’s Strategic Advisory Services practice. He advises innovative enterprises on cost-effective strategic management of their intellectual assets, and creates monetization and transaction strategies for maximum value creation.Novel Models of Biotech IP Licensing: How Early Can it Start?
Dr. Cech was raised and educated in Iowa (B.A. in chemistry from Grinnell College, 1970). He obtained his Ph.D. in chemistry from the University of California, Berkeley.The Long Road to Personalized Medicine: How Mutations Activate a Telomerase Gene and Help Drive Cancer A guided discussion with panelists led by Tom Cech
Diana Chapman Walsh serves on the governing boards the Broad Institute of MIT and Harvard; the Kaiser Family Foundation; the Institute for Healthcare Improvement; the Massachusetts Institute of Technology; and the Mind and Life Institute, and on several national advisory boards.Educating Our Smartest Kids to Tackle the Big Problems in Healthcare
Ben Coles is a broadly trained economic and political geographer who researches the intersections between commodities and markets, with a particular focus on food.The Anthropocene Chicken and the ‘Wicked’ Problem(s) of Contemporary Food
Dr. Coors is Associate Professor in the Department of Psychiatry. Her teaching and scholarship focus on advances in genetics and the implications for what it means to provide health care in the age of genetic medicine.
Neal Copeland received his Ph.D. in biochemistry from the University of Utah and carried out his postdoctoral training at Harvard Medical School, where he met his long-time collaborator and wife, Nancy Jenkins. After their postdoctoral training, they moved to The Jackson Laboratory where they were associate staff scientists.Exploring the Evolutionary Forces Driving Tumor Development
Ruth Crowe was trained as a physician-scientist at NYU School of Medicine and received residency and Hematology-Oncology fellowship training at Cornell University Medical College.Healthcare on the Ground: New Challenges for Physicians
Scott Danielson is a tinkerer, inventor and entrepreneur who creates high-impact, high-value, customer-centered products and services.Patient-Centered Care Perspectives: Views from Where We Stand, Sit, and Lie Down Changing Minds: You Don’t Know the Half of It
Daniel Dennett is Co-Director of the Center for Cognitive Studies at Tufts University, and Austin B. Fletcher Professor of Philosophy.
Robin Deterding is a tenured professor of pulmonary medicine in the Department of Pediatrics at the University of Colorado Anschutz Medical Campus and Children’s Hospital Colorado.A Journey to Transform Care for Children with Rare Lung Disease
Lakshmi Devi received her PhD from the University of Windsor in Ontario, Canada and postdoctoral training at the Vollum Institute, Portland, Oregon, and Addiction Research Foundation, Palo Alto, California.Big Science on a Small Budget: Neuropeptide Receptors and Drug Discovery
Robert Duke is the Marlene and Morton Meyerson Centennial Professor and Head of Music and Human Learning at The University of Texas at Austin, where he is University Distinguished Teaching Professor, Elizabeth Shatto Massey Distinguished Fellow in Teacher Education, and Director of the Center for Music Learning.How We Learn… and How We Don’t Changing Minds: You Don’t Know the Half of It
Paul Ehrlich is the Bing Professor of Population Studies, president of the Center for Conservation Biology, at Stanford University, and adjunct professor at University of Technology, Sydney. His research is in population biology, which includes ecology, evolutionary biology, behavior, human ecology, and cultural evolution.Diet and Hunger: The Weakest Parts of the Global “Health Care”
Caldwell B. Esselstyn, Jr., received his B.A. from Yale University and his M.D. from Western Reserve University. In 1956, pulling the No. 6 oar as a member of the victorious United States rowing team, he was awarded a gold medal at the Olympic Games.Becoming Heart Attack Proof and Ending the Coronary Artery Disease Epidemic
Marc Feldmann is a professor at the Kennedy Institute of Rheumatology at the University of Oxford. He trained in medicine at Melbourne University and then earned a Ph.D. in Immunology at the Walter & Eliza Hall Institute with Sir Gus Nossal.Can We Define a More Cost-Effective Path to Better Therapy? Reminiscences from the Front Line
Elizabeth Fenn is the chair of the History Department at the University of Colorado Boulder, where she is the Walter and Lucienne Driskill Professor of Western American History.Pox Americana: The Great Smallpox Epidemic of 1775-82
Dr. Susan Fisher is a Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at the University of California, San Francisco, School of Medicine.Transforming Prenatal Care: Personalized Medicine Begins in the Womb
Garret A. FitzGerald, MD, is the McNeil Professor in Translational Medicine and Therapeutics at the University of Pennsylvania in Philadelphia, where he chairs the Department of Pharmacology and directs the Institute for Translational Medicine and Therapeutics.Opportunities and Challenges in Translational Therapeutics
Peptides play many important physiological roles in most organisms. Neuropeptides and peptide hormones function in cell-cell signaling and are involved with a wide variety of biological functions including feeding and body weight regulation, fear, anxiety, pain, circadian rhythms, memory, reward mechanisms, and many others.Peptides, Drug Discovery, Serendipity, and Basic Science
Pat Furlong is the Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non profit organization in the United States solely focused on Duchenne muscular dystrophy (Duchenne).The Parent Project: Advocating for Children’s Health
Dr. Ganz is the Chief of Cardiology and the Director of the Center of Excellence in Vascular Research at the San Francisco General Hospital.High Levels of Growth Differentiation Factor 11 Are Associated With Lower Prevalence of Left Ventricular Hypertrophy, Heart Failure and Mortality
Julie Gerberding is Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health at Merck & Co., Inc., where she also has responsibility for the “Merck for Mothers” global program to prevent maternal mortality and the Merck Foundation.Antimicrobial Resistance: Newest Thugs without Drugs
Elodie Ghedin is a Professor of Biology and Global Public Health and a member of the Center for Genomics and Systems Biology at New York University. Her laboratory uses comparative genomics, evolutionary biology, and systems biology techniques to generate critical insights about host-pathogen interactions.Frenemies: Microbial Interactions in Respiratory Diseases
Larry Gold serves as the Founder and Chairman of the Board of SomaLogic, and is a Professor at the University of Colorado Boulder.One to Five, Six to Ten Opening Remarks 2014 Closing Remarks 2014 Opening Remarks 2013 Opening Remarks 2012 Opening Remarks 2011 Closing Remarks 2010 Opening Remarks 2010
Keith Gottesdiener, M.D., is Chief Executive Officer of Rhythm Pharmaceuticals, Inc., a Boston based biotech company that specializes in the development of peptide therapeutics for the treatment of metabolic diseases, such as diabetes, obesity and functional GI disorders.The Gardasil Story: A Vaccine to Prevent Cervical Cancer
Casey Greene’s lab at the University of Pennsylvania is dedicated to developing computational tools that biologists use to gain insights from other labs’ data as easily as from their own. More than 2 billion dollars’ worth of publicly funded genomics data are freely downloadable.Gone Fishing
Leslie Greengard is the director of the Simons Center for Data Analysis, at the Simons Foundation, and a professor of Mathematics and Computer Science at the Courant Institute of New York University, where he served as the director from 2006-2011.Opportunities and Challenges for Big Data in Biology: The Good, the Bad, and the Ugly
Rick Guidotti, an award-winning fashion photographer, has spent the past fourteen years working internationally with advocacy organizations/NGOs, medical schools, universities and other educational institutions to effect a sea-change in societal attitudes towards individuals living with genetic difference.Neglected Diseases are All of Us
Tim Harris is a science and business leader with over 30 years of experience guiding and leading laboratory work and scientists in a range of research areas.Drug Discovery and Development: It’s All about Human Genetics Really
Joan Henneberry is a Vice President supporting colleagues in multiple Health Management Associates (HMA) offices across the country, and working with government, and private sector clients to implement state and federal health reform programs; developing new business models and partnerships that allow specialty providers to be part of new networks and new service delivery approaches; and assisting healthcare organizations with market assessments and business planning.The Value of Medicaid: Trends and Threats in 2018
An MIT engineer, Jamie entered the field of translational research and medicine when his brother Stephen was diagnosed with ALS at age 29.Patient Driven Real Time Outcome Management and Research
Kevin Hickerson’s research in particle physics focuses on neutrons and neutrinos. He is an academic lecturer, stand-up comic, tinkerer with many patents, Hollywood science consultant, and hosts the science and comedy podcast, Surely You’re Joking.‘Who the Hell Ate All the Frozen Neutrons?’ and Other Hilarious Adventures
James O. Hill, Ph.D. is Professor of Pediatrics and Medicine at the University of Colorado School of Medicine, James O. Hill, Ph.D. is the Founding Executive Director of the Colorado Center for Health and Wellness at the University of Colorado Anschutz Medical Campus.The Challenge of Healthy Living
Joy Hirsch, Ph.D., is a neuroscientist and currently a Professor of Psychiatry and Neurobiology at Yale University, in New Haven, CT.From the Autistic Brain to the Autistic Mind and Beyond
Paula Hoffman is a tenured professor of pharmacology in the University of Colorado School of Medicine.Everyone Knows About Alcohol–But What Do We Really Know?
Dr. Lawrence Hunter is the Director of the University of Colorado’s Computational Bioscience Program and a Professor of Pharmacology (School of Medicine) and Computer Science (Boulder).Computational Bridges over the Chasms between Science, Medicine and Health
Dr. Lawrence Hunter is the Director of the University of Colorado’s Computational Bioscience Program and a Professor of Pharmacology (School of Medicine) and Computer Science (Boulder).Computational Bridges over the Chasms between Science, Medicine and Health Artificial Intelligence and Medicine
Clyde Hutchison obtained his B.S. in Physics from Yale. As an undergraduate, he worked on bacterial spore germination with Carl Woese, then a postdoctoral fellow in the lab of Harold Morowitz. His Ph.D. research, in the laboratory of Robert L. Sinsheimer at Cal Tech, concerned the genetics of bacteriophage phiX174.Design, Construction, and Analysis of a Minimal Bacterial Cell
Michael J. Joyner, M.D., is the Caywood Professor of Anesthesiology at Mayo Clinic where he was named distinguished investigator in 2010. His interests include exercise physiology, blood pressure, metabolism, and transfusion practices.Is Reductionism Killing Biomedical Research?
David Juncker studied at the Institute of Microtechnology of the French speaking University of Neuchâtel, and received a degree in Electronics–Physics in 1996.The Transformation of Society by Microchips and Scalable Technologies: From Computers to Healthcare
Peter S. Kim is a structural biologist known for discovering how proteins cause membranes to fuse, a central feature of all life. He has designed novel compounds that stop membrane fusion by the AIDS virus, thereby preventing it from infecting cells, and has pioneered efforts to develop an HIV vaccine based on similar principles.Towards an HIV Vaccine
After a brief career in television comedy, Daniel Klein began writing books, ranging from thrillers and mysteries to humorous books about philosophy, including the New York Times bestseller Plato and a Platypus Walk into a Bar – Understanding Philosophy Through Jokes.The Philo-Gag Perspective I The Philo-Gag Perspective II Death and Its Prequel
Yvonne Kobayashi is a principal research scientist at Eli Lilly & Company and came to the Mobility & Metabolism Division at the end of 2012.Duchenne Muscular Dystrophy: A Not-So-Rare Disease
Daniel Kracov is a Partner and Head of the FDA and Healthcare Regulatory Practice Group at Arnold & Porter LLP.Personalized Medicine: Facilitating a Partnership with the FDA
A graduate of the University of London, where he went on to earn a master’s degree in computer science and mathematics, David Krakauer received his D.Phil. in evolutionary theory from Oxford University in 1995.The Stupid Ways That We Have Thought About Intelligence
Don Kripke was born in Schenectady, NY, and raised in Washington, D.C. He graduated magna cum laude from Yale with a BA in Philosophy in 1963. He then attended the University of Pennsylvania School of Medicine, where he received his M.D. degree in 1967.Psychiatry: Is It Different? If So, How?
Greg LaGana, M.D., completed an internal medicine internship and residency at Harlem Hospital and is board-certified in internal medicineDamaged Care: The Musical Comedy About Health Care in America
Larry is an expert in biotechnology, a field that he has worked in commercially for over 27 years. In 1981, he was a founding scientist of Genetics Institute (acquired by Wyeth), one of the earliest biotechnology companies.Pathway-Specific Medicines: 21st Century Solutions to Unmet Medical Needs
For too long in America health has been defined as simply not being sick. But health is so much more than that. Health is everything. It is influenced by a complex web of social factors: Where we live, how we work, the soundness and safety of our surroundings, and the strength and resilience of our families and our communities.Building a Culture of Health in America: Why Health is Everything
Dr. Lawrence served as CEO and Chairman of Kaiser Foundation Health Plan and Hospitals until his retirement in 2002. He was appointed CEO in 1991 and Chairman the next year.Looking Back: Peeking Into the Future Growing Pains: The Evolution Toward Consumer-Driven Medicine
Dr. Leinwand is a Professor of Molecular, Cellular, and Developmental Biology and Chief Scientific Officer of the Colorado Initiative in Molecular Biotechnology at the University of Colorado, Boulder.
Richard C. Levin recently completed a twenty-year term as Yale’s President. He received his B.A. from Stanford University in 1968 and studied politics and philosophy at Oxford University, where he earned a B.Litt. degree.The American Research University: Achievements, Challenges, and Responses
Barry Levy, M.D., M.P.H., completed an internal medicine residency at University Hospital and the Beth Israel Hospital in Boston, and a preventive medicine residency at the Centers for Disease Control. He is board-certified in internal medicine and occupational medicine.Damaged Care: The Musical Comedy About Health Care in America
Allen Lim received his doctorate from the Applied Exercise Science Laboratory in the Department of Integrative Physiology at the University of Colorado Boulder under the direction of Dr. William Byrnes.
Simon Lovestone is Director of Research, King’s Health partners, Professor of Old Age Psychiatry at the Institute of Psychiatry, King’s College London.Biomarkers for Alzheimer’s disease: Not Necessarily Desirable but Definitely Essential
Stephen Macknik is Laboratory Director at the Barrow Neurological Institute. He is an award winning scientist and his book, along with Dr. Susana Martizez-Conde, Sleights of Mind, is an international bestseller recognized as one of the Top 36 Books of the Year by The Evening Standard.Champions of Illusions
Mr. Mahaffy is a founder of Clovis and has served as its President and Chief Executive Officer and a member of its board of directors since its inception.
Dr. Malone began her scientific career wearing hip-waders in a swamp behind her home in Illinois. She earned her B.S in Biology at Illinois State University and her PhD in Microbiology and Immunology at UCLA.Alternative Pedagogy for the Scientifically Refractive Learner
Tony Marion is a professor in the department of microbiology, immunology, and biochemistry at the University of Tennessee Health Science Center in Memphis.Chance, Genetics, and the Heterogeneity of Autoimmunity and Disease Pathogenesis in Systemic Lupus Erythematosus
Dr. Marrack has studied T cells, how they are created and how they operate for good or ill for more than 40 years, almost since the cells were discovered.Vaccines: How They Work and Whether They are Good for You
Jessica Mathews is a distinguished fellow at the Carnegie Endowment for International Peace. She served as Carnegie’s president for 18 years. Before her appointment in 1997, her career included posts in both the executive and legislative branches of government, in management and research in the nonprofit arena, and in journalism and science policy.Rethinking U.S. Foreign Policy
Jennifer McCrea is a senior research fellow at the Hauser Institute for Civil Society at Harvard University and the co-founder and CEO of Born Free Africa, an initiative that brings private sector resources and expertise to the goal of eradicating mother-to-child transmission of HIV by 2015.Generosity Becomes You
Jennifer McCrea is a senior research fellow at the Hauser Institute for Civil Society at Harvard University and the co-founder and CEO of Born Free Africa, an initiative of the Millennium Development Goals Health Alliance that brings private sector resources and expertise to the goal of eradicating mother-to-child transmission of HIV.Generosity Becomes You
Steven L. McKnight received a bachelor’s degree in biology from the University of Texas in 1974 and his Ph.D. degree in biology from the University of Virginia in 1977.A Solid State Conceptualization of Information Transfer from Gene to Message to Protein
Mark Messenbaugh serves as SomaLogic’s Chief Corporate Strategy and Development Officer, where he is responsible for developing and structuring key business opportunities and third-party collaborations.
Charles R. “Chuck” Middleton has had a long and distinguished career in higher education, currently serving as Roosevelt University’s 5th president.Giving the Patient a Choice: Democratizing Medical Service
Matt Might is an active advisor to the newly established Undiagnosed Disease Network Coordinating Center at Harvard University. He is passionate about patient-driven precision medicine, accelerating drug development in rare disease, and bending the cost curve in medical research with computation and social media.One of a Kind: What Do You Do When You’re the First?
Carl Morris is the SVP of Research and Development at Solid Biosciences where he is responsible for overseeing the company’s drug development activities. Prior to joining Solid, Carl was a Senior Director for Pfizer’s Rare Disease Research Unit, leading their efforts in neurologic diseases and the muscle biology programs.Developing a Gene Therapy for Muscular Dystrophy
Steve Morrissett is a trial lawyer in the Palo Alto, California, office of Finnegan, Henderson, Farabow, Garrett & Dunner, a law firm that practices exclusively intellectual property law.A Curious Collision: Innovation vs. Patent Protection in Health Care
Craig J. Mundie is President of Mundie & Associates. He joined Microsoft in 1992 and became the Principal Technology-Policy Executive. In 2014, he retired from Microsoft as Chief Research and Strategy Officer. Previously he was CEO and co-Founder of Alliant Computer Systems.How Machine Intelligence Could Accelerate Holographic Medical Imaging
Professor Nicholson obtained his BSc from Liverpool University (1977) and his PhD from London University (1980) in Biochemistry working on the application of analytical electron microscopy and the applications of energy dispersive X Ray microanalysis in molecular toxicology and inorganic biochemistry.Supersystems Biology and Systems Medicine in the Clinic: A Translational Journey
Emanuel Petricoin has been the co-director of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University since 2005, where he is a university professor.Clinical Proteomics for Diagnostics and Precision Medicine: Applications in the Post-Genome Era
Gregory A. Petsko is Chair of the Department of Biochemistry at Brandeis University in Waltham, Massachusetts, where from 1994 to 2008 he served as Director of the Rosenstiel Basic Medical Sciences Research Center.The Coming Worldwide Epidemic of Neurological Disorders, and What We’re Doing About It
Dr. Pollak has devoted his career to fostering solutions that personalize and improve care around the needs of the whole patient, reducing the clinical, financial and lifestyle risks of healthcare for individuals and organizations alike.
Dr. George Poste is Chief Scientist, Complex Adaptive Systems Initiative (CASI) at Arizona State University. This program links expertise across the university in research on synthetic biology, ubiquitous sensing and Healthcare informatics for personalized medicine.Sustaining Healthcare Innovation in an Era of Constraint
Training: Medical degree with honors from the University of West Indies; Oxford University (Rhodes Scholar); MA Physiology. Internal medicine residency Mayo Clinic.The Problems, Premise, and Promise of Personalized Oncology
Anna Marie Pyle is the William Edward Gilbert Professor of Molecular, Cellular and Developmental Biology, professor of chemistry at Yale University, and an investigator with the Howard Hughes Medical Institute.New Defenses for the Body’s Own Armor: RNA Weapons Against RNA Viruses
David Quammen is an author and journalist who lives in Montana and travels widely for research, usually to jungles and mountains and swamps. His fifteen books include The Song of the Dodo, The Reluctant Mr. Darwin, Spillover—a work on the science and history of dangerous zoonotic pathogens—including Ebola and HIV, and Yellowstone: A Journey through America’s Wild Heart.Carl Woese and the Non-Tree of Life
Steve Reed is the Founder, President, and CSO of the Infectious Disease Research Institute (IDRI). His academic appointments include Professor of Medicine at Cornell University Medical College in New York and Research Professor of Pathobiology at the University of Washington.Novel Adjuvants For New Vaccines
Evelyn Resh is a certified sexuality counselor, nurse-midwife, author and speaker. She frequently speaks and writes about sexual health and satisfaction and mother-daughter relationships.Men, Women, Sex, and Power – How Health, Confidence and Pleasurable Living Support Sexual Desire
John L. Rinn is the Alvin and Esta Star Associate Professor of Stem Cell and Regenerative Biology at Harvard University and Harvard Medical School, and senior associate member of the Broad Institute.Transposable Elements Modulate Human RNA Abundance
Bill Robinson is a Professor of Medicine and the Rifkin Endowed Chair for Cancer Research at the University of Colorado, Anschutz Medical Campus.Malignant Melanoma: The Tumor That Used to Give Cancer a Bad Name
Gene E. Robinson received a Ph.D. from Cornell University in 1986 and joined the faculty of the University of Illinois at Urbana-Champaign in 1989. He holds a university Swanlund Chair, is the director of the Carl R. Woese Institute for Genomic Biology (IGB), and director of the Bee Research Facility.Me to We: Searching for the Genetic Roots of Sociality
William N. Rom M.D., MPH is the Sol and Judith Professor of Medicine and Environmental Medicine at New York University School of Medicine and Director of the Division of Pulmonary and Critical Care Medicine.Protein Biomarkers: A Blood Test for Early Stage Non Small Cell Lung Cancer
William J. Rutter, PhD is Founder and Chairman and CEO of Synergenics, LLC, which controls a consortium of companies with different but complimentary approaches to diagnosis, prevention and treatment on a worldwide basis.Empowering Individuals to Control Their Health Status: Improving the Efficiency of the Healthcare System at all Levels
Sara Sawyer is as Associate Professor in the BioFrontiers Institute at the University of Colorado Boulder. She is a recognized expert in “zoonotic” viruses such as Ebola, HIV, and Zika, which emerge from animal reservoirs and enter the human population.Zika, Ebola, and Dengue: Viruses Emerging from the Human – Animal Interface
Jack Scannell studies biomedical R&D productivity from both an economic and a scientific perspective, particularly the unpalatable contrast between cheaper and better scientific inputs, and what has been a long-term decline in innovative output efficiency.“Damn the Compass, Full Speed Ahead”: Why Quality Beats Quantity in Drug R&D
Raymond F. Schinazi is the Frances Winship Walters Professor of Pediatrics and Director of the Laboratory of Biochemical Pharmacology at Emory University and Co-Director of the HIV Cure Scientific Working Group for the NIH-sponsored Emory University Center for AIDS Research (CFAR).
Lucy Shapiro is a Professor in the Department of Developmental Biology at Stanford University School of Medicine where she holds the Virginia and D. K. Ludwig Chair in Cancer Research and is the Director of the Beckman Center for Molecular and Genetic Medicine.The Bugs are Winning in our Changing Global Health Landscape
Howard-Yana Shapiro has been involved with sustainable agricultural and agroforestry systems, plant breeding, molecular biology, and genetics for over 40 years. He has worked with indigenous communities, NGO’s, governmental agencies and the private sector around the world.Stunting, Caused by Chronic Hunger and Malnutrition, is a Crime Against Humanity
Kenneth E. Sharpe is the William R. Kenan, Jr. Professor of Political Science at Swarthmore College where he teaches political philosophy, practical ethics, Latin American politics, and foreign policy.Designing for Patient Centered Care When There Is No Cure
Dr. Shay is a psychiatrist whose treatment of combat trauma suffered by Vietnam veterans combined with his critical and imaginative interpretations of the ancient accounts of battle described in Homer’s Iliad and Odyssey are deepening our understanding of the effects of warfare on the individual.JUST ONE CRITTER: Brain, Mind, Society, Culture at the Same Ontological Level
Neil Siegel, Ph.D. is sector vice-president & chief technology officer at Northrop Grumman. In this position, he has been responsible for the creation of many first-of-their-kind, large-scale, high-reliability systems for the U.S. Government and other customers.Closed-loop Healthcare Processing: The Use of Proteomics and Information Technology to Improve Healthcare
As Medco’s Chairman and Chief Executive Officer, David B. Snow, Jr., architected the transformation of Medco Health Solutions into an enterprise that is today recognized as one of the world’s most admired and innovative companies, and a leader in clinically driven pharmacy care that empowers the practice of precision medicine.Improved Interventions: Drug Use and Best Practices
Fintan Steele joined SomaLogic in 2011 as executive director for communications. Fintan’s background includes more than 20 years of experience in communicating scientific research, particular the science (and its implications) behind the “omics revolution.”Time: Personalized Medicine’s Final Frontier
Our research combines mouse genetics, bioinformatics and genomic methods to explore cis- and trans-acting components of mammalian gene regulatory machinery.A Conserved Regulatory Core — With Species-specific Innovations — at the Root of Shared Behaviors
John Swindle is the co-founder, President and CEO of CompleGen, Inc. in Seattle, WA and co-inventor of the Company’s core XenoGene technology.Drug Discovery: Infinitely Complex but Don’t Overthink It
Dr. Teitell is a Professor in the Department of Pathology & Laboratory Medicine, in the Department of Pediatrics, and in the Bioengineering Interdepartmental Program at the University of California, Los Angeles.Photothermal Nanoblade and Nucleic Acid Import into Mitochondria: Can We Improve Bioenergetics for People?
Sharon F. Terry is President and CEO of the Genetic Alliance. She is the founding CEO of PXE International, a research & advocacy organization for the genetic condition pseudoxanthoma elasticum (PXE), a condition that affects her two children.Rare and Neglected Diseases: The Time is Now!
Dan Theodorescu, MD, Ph.D. is the Director of the National Cancer Institute (NCI) designated Comprehensive Cancer Center at the University of Colorado where he is also a Distinguished University Professor. Dan is known for his work on the molecular mechanisms underlying bladder cancer and tools that determine drug response as well as discovery of new drugs for cancer.Translating Cancer Biology into Novel Therapies
Matthew Todd’s research interests include the development of new ways to make molecules, particularly how to make chiral molecules with new catalysts.Open Source Drug Discovery – A Limited Liability Tutorial
Dr Mathias Uhlen is Professor of Microbiology at the Royal Institute of Technology (KTH), Stockholm, Sweden. Dr Uhlen is member of the Royal Swedish Academy of Engineering Science (IVA), the Royal Swedish Academy of Science (KVA), the European Molecular Biology Organization (EMBO) and member of the Human Proteome Organization (HUPO) council.Exploring the Human Protein Atlas to Study Biology and Disease
Christopher Walsh is the Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology (BCMP) at Harvard Medical School.Antibiotics Past, Present, and Future: At the Academic/Biotech Interface
Harriet Warshaw is the executive director of The Conversation Project, a public engagement campaign dedicated to helping people talk about their wishes for end-of-life care.Having the Conversation: Is It Really That Important?
Robert A. Weinberg is a founding member of the Whitehead Institute for Biomedical Research and the Daniel K. Ludwig Professor for Cancer Research at the Massachusetts Institute of Technology (MIT). Bob and his colleagues isolated the first human cancer-causing gene, the ras oncogene, and the first known tumor suppressor gene, Rb, the retinoblastoma gene.Epigenetic Programs and Cancer Progression
Dr. Williams trained as a physician at Charing Cross and Westminster medical school, University of London, and following his internships returned to the same institution for a Ph.D. in medicine and physiology.Monitoring Wellness: Blood Tests for Many Diseases Aphrodite and Medusa: Portraying the Beauty of Biology and the Gorgon of Disease
One of society’s greatest challenges today is to improve health and achieve health equity for all at lower cost. I will speak about the plan of the Colorado Longitudinal Study (COLS) to create the largest, longitudinal repository of biological specimens and associated community and public health data in the world.The Colorado Longitudinal Study: A Road to Better Health and Health Equity
Dr. Wohlgemuth is Vice President of Science & Innovation of the Quest Diagnostics Nichols Institute in San Juan Capistrano, CA.Diagnostics in the Reference Labs: Putting the Patient First
Dr. Nathan Wolfe is an epidemiologist who fights disease pandemics with an unprecedented early warning system to forecast, pinpoint and control new plagues worldwide before they kill millions.Before It Strikes: Viral Forecasting For Pandemic Prevention
Stephan Wolfert left a career in the military for a life in the theatre after seeing Shakespeare’s Richard III. Stephan received his Master of Fine Arts degree from Trinity Repertory Conservatory in Providence, Rhode Island. On Broadway, Stephan created and directed the military segments for Twyla Tharp & Billy Joel’s Tony-Award winning production Movin’ Out and has been a character coach for Cirque du Soleil’s, Mystere.DE-CRUIT® Treating Trauma Through Shakespeare and Science